Metzger Michael A sold SNDX
February 6, 2026 · Form 4 insider transaction
Metzger Michael A sold 7,412 shares of Syndax Pharmaceuticals, Inc. at $20.62 per share, a transaction worth $152.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,412
Price
$20.62
Total value
$152.8K
InsiderMetzger Michael A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 6, 2026
Filing dateFebruary 6, 2026
Shares owned after508,849
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.